Merck KGaA, Darmstadt, Germany, Announces Two New Appointments to Group Leadership Positions
- Tina Sandmann appointed Head of Internal Auditing
- Barbara Weiland to become Chief Compliance Officer
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced two new appointments to Group leadership positions that will take effect on July 1. Tina Sandmann will become Head of Internal Auditing. She will report to Stefan Oschmann, Chairman of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. Sandmann succeeds Barbara Weiland, who will become Chief Compliance Officer on the same date and report to Friederike Rotsch, Group General Counsel and Head of Group Legal and Compliance.
“We place great importance on promoting the development of highly qualified employees. Therefore, I am very proud that we have been able to fill both of these important positions with internal candidates,” said Oschmann.
Sandmann, who began working for Merck KGaA, Darmstadt, Germany, in 2008, has held positions within Group Legal, in the Sigma-Aldrich Integration Office and has served as Chief Financial Officer of the Healthcare business in Germany, among other things. Most recently she led a key senior project at Group level. Sandmann, a lawyer who studied and earned a doctorate in Frankfurt, Germany, worked for the legal firm Freshfields Bruckhaus Deringer before joining Merck KGaA, Darmstadt, Germany.
Weiland started her career at Merck KGaA, Darmstadt, Germany, in 2005 in Management Development. Afterwards, she was responsible for Group functions within Human Resources. Before joining Merck KGaA, Darmstadt, Germany, Weiland worked in Human Resources at Lufthansa. She studied business psychology in Würzburg, Germany.
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register for your online subscription of this service as our geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 52,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2018, Merck KGaA, Darmstadt, Germany, generated sales of € 14.8 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.
Merck KGaA, Darmstadt, Germany, has acquired Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the “Breez™”.